Skip to main content

Day: May 8, 2024

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Bank of America Securities 2024 Healthcare Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at 1:40 p.m. ET / 10:40 a.m. PT on May 15, 2024. A live audio webcast of the fireside chat will be available in the Investors section of Kura’s website at www.kuraoncology.com, with an archived replay following the event. About Kura Oncology Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists...

Continue reading

FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update

OMAHA, NE, May 08, 2024 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the Sidoti Virtual Investor Conference on Wednesday and Thursday, May 8-9, 2024.  The Company’s presentation will begin at 1:45pm EDT on May 9, 2024, and can be accessed live at the following link: https://sidoti.zoom.us/webinar/register/WN_VDHnrzFZSqGQgICgizO8ew.  FitLife will also host virtual one-on-one meetings with investors on Wednesday and Thursday, May 8-9, 2024.  To register for the presentation or for a one-on-one meeting, please visit www.sidoti.com/events.  Registration is free and participants do not need to be a Sidoti client. In conjunction with its participation in the conference,...

Continue reading

BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity

— New therapeutic candidate developed using Company’s patented ThermoStem® platform — — Candidate has potential to serve as an adjuvant to existing pharmaceuticals that are FDA approved and marketed towards weight loss — — DMF submission and commencement of first-in-human studies targeted for before the end of 2024 — — Expanding the use of ThermoStem® may open the door to big pharma partnership opportunities — MELVILLE, N.Y., May 08, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced its development of a novel exosome-based biologic program targeting obesity. BioRestorative currently anticipates initiating the formal U.S. Food and Drug Administration (“FDA”) process for this ThermoStem®-based...

Continue reading

HPQ Silicon Signs MOU With Impact Funding Europe for Collaboration on EU Funding Programs

MONTREAL, May 08, 2024 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials, announces the signing of a Memorandum of Understanding (MOU) with Impact Funding Europe (IFE), a distinguished expert in international EU grant writing and change management. The objective of the MOU is to leverage HPQ’s expertise in green engineering of silica and silicon-based materials and IFE’s capability of securing funding under EU programs to advance HPQ’s projects. “We are delighted that we can now include HPQ technologies in our innovation projects, like BlueTEC parcs or Collaborative Research Projects,” said Business Architect and Co-founder Olaf-Gerd Gemein. “In Europe, the available funding for Green Deal...

Continue reading

WEMADE and WEMIX Win “Best Web3 Gaming” at MENA Games Industry Awards 2024

Wemade is at the forefront of the next wave of Web3 game developers that are innovating with blockchain technology. SEOUL, SOUTH KOREA, May 08, 2024 (GLOBE NEWSWIRE) — WEMADE and WEMIX were honored with the prestigious “BEST WEB3 GAMING ” award at the MENA Games Industry Awards 2024. The awards celebrate the best of the region’s thriving gaming sector, and as the sole web3-focused award, the “BEST WEB3 GAMING” category spotlights companies championing the integration of web3 technologies into gaming. “We are honored to receive this prestigious award. It validates Wemade’s commitment to fostering growth and collaboration within the global web3 gaming landscape,” Wemade said in a statement. “This award motivates us to continue empowering developers and driving innovation...

Continue reading

Ladybug Signs LOI to Purchase Ecommerce Site from Your Supplement Supply Store Ltd.

TULSA, Okla., May 08, 2024 (GLOBE NEWSWIRE) — Ladybug Resource Group, Inc. (OTC PINK: LBRG), now operating under the brand name Ladybug NutraTech, is excited to announce the signing of a Letter of Intent for the acquisition of a leading e-commerce platform from Your Supplement Supply Store Ltd. This strategic move marks a significant milestone in Ladybug NutraTech’s expansion and enhancement of its digital retail footprint. This e-commerce platform has been designed to serve a niche market comprising busy professionals, day traders, and cryptocurrency traders. This demographic is known for its demanding schedules and unique lifestyle needs, requiring quick and efficient nutritional solutions. The website offers a curated selection of products tailored for this group, including meal replacement shakes, energy boosters, and...

Continue reading

Atlantica Reports First Quarter 2024 Financial Results

Revenue for the first quarter of 2024 remained stable at $242.9 million, compared with $242.5 million in the first quarter of 2023. Adjusted EBITDA was $164.2 million, a 0.9%1 year-over-year decrease on a comparable basis. Net loss for the first quarter of 2024 attributable to the Company was $5.4 million, compared with a net loss of $11.0 million in the first quarter of 2023. Operating Cash Flow increase of 57.3% year-over-year up to $65.6 million.    Signed a 15-year PPA for a 100 MW solar + storage project in California. Closed the acquisition of two wind assets in operation in the UK at 6.6x EV2 / EBITDA3 multiple. Quarterly dividend of $0.445 per share approved by the Board of Directors. Strategic Review ongoing.              May 8, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”) today...

Continue reading

Vishay Intertechnology Reports First Quarter 2024 Results

MALVERN, Pa., May 08, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive electronic components, today announced results for the fiscal first quarter ended March 30, 2024. Highlights1Q 2024 revenues of $746.3 million Gross margin was 22.8% and included the negative impact of 74 basis points related to the addition of Newport EPS of $0.22 1Q 2024 book-to-bill of 0.82 with book-to-bill of 0.73 for semiconductors and 0.91 for passive components Backlog at quarter end was 5.0 months“As expected, first quarter revenue declined 5% sequentially primarily due to ongoing semiconductor inventory digestion and lingering macro-economic uncertainties, particularly in Asia and Europe. Passive components revenue is stable to growing in Automotive...

Continue reading

Gilat Reports First Quarter 2024 Results

Strong Revenue Growth of 29% Year-over-Year, GAAP Operating Income of $5.4 Million and Adjusted EBITDA of $9.3 Million PETAH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today reported its results for the first quarter, ended March 31, 2024. First Quarter 2024 Financial HighlightsRevenue of $76.1 million, up 29% compared with $59.0 million in Q1 2023; GAAP operating income of $5.4 million, compared with $7.0 million in Q1 2023;The decline is mainly due to lower other income, higher stock-based compensation, mainly related to the Datapath acquisition, and amortization of purchased intangibles;Non-GAAP operating income of $6.6 million, up 25% compared with $5.3 million in Q1 2023; GAAP...

Continue reading

Vertex Announces First Quarter 2024 Financial Results

KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2024. “The year is off to a solid start, and I am very pleased with our financial performance in the first quarter,” stated David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board. “Revenue traction is strong in the first quarter, with our cloud solutions leading the way, and we are seeing significant earnings leverage that is driving material growth in profitability as well as cash flow. The current momentum in our business, combined with our strengthened balance sheet following our recent successful convertible debt offering, give me confidence in our ability to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.